Advertisement

Topics

Shire sells cancer biz for $2.4bn

09:00 EDT 17 Apr 2018 | BioPharma-Reporter

Shire has sold its oncology business to French firm Servier S.A.S as it looks to better align its long-term strategy.

Original Article: Shire sells cancer biz for $2.4bn

NEXT ARTICLE

More From BioPortfolio on "Shire sells cancer biz for $2.4bn"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...